B-type natriuretic peptide (BNP) or N-terminal-proBNP for the diagnosis of heart failure: Which peptide is the better choice?

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 8, 2005, Pages 629-632

  Kragelund, C ^a   Omland, T ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HORMONE PRECURSOR;

ANALYTIC METHOD; AUTOANALYZER; CARDIOPULMONARY HEMODYNAMICS; CONTRAST ECHOCARDIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; EARLY DIAGNOSIS; EDITORIAL; ELECTROCARDIOGRAPHY MONITORING; HEART DISEASE; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE PERFORMANCE; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; ROC CURVE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; HEART DISEASES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 28744449019     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510500429763     Document Type: Editorial

References (17)

1. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21.
2. Redfield MM, Jacobsen SJ, Burnett JC, Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
3. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
4. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
5. Bruneau BG, Piazza LA, De Bold AJ. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 1997;273:H2678-86.
6. Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287-96.
7. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996;76:232-7.
8. Luchner A, Hengstenberg C, Lowel H, et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 2002;39:99-104.
9. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000;36:355-9.
10. Johnson W, Omland T, Hall C, et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002;39:1623-9.
11. Downie PF, Talwar S, Squire IB, et al. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction. Clin Sci (Lond) 1999;97:255-8.
12. Muders F, Kromer EP, Griese DP, et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 1997;134:442-9.
13. Daggubati S, Parks JR, Overton RM, et al. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res 1997;36:246-55.
14. Yandle T, Fisher S, Espiner E, Richards M, Nicholls G. Validating aminoterminal BNP assays: a word of caution. Lancet 1999;353:1068-9.
15. McGeoch G, Lainchbury J, Town GI, et al. Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Fail 2002;4:479-83.
16. Tang WH, Girod JP, Lee MJ, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003;108:2964-6.
17. Raymond I, Groenning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745-51.